跳至主要内容
临床试验/DRKS00011827
DRKS00011827进行中(未招募)3 期

Vitamin D in secondary prevention of benign paroxysmal positional vertigo: a prospective, multicenter, randomized, placebo-controlled, double-blind study - VitD@BPPV

Deutsches Schwindel- und Gleichgewichtszentrum DSGZ und Neurologische Klinik, Klinikum der Universität München0 个研究点目标入组 59 人开始时间: 2017年3月22日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
59

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Written informed consent to participation in the study
  • Age = 18 years
  • Patients with BPPV of the posterior, horizontal or anterior semicircular canal (confirmed by diagnostic maneuvers) of different etiologies
  • (idiopathic, traumatic, other vestibular diseases)
  • The ability to follow study instructions and likely to attend and complete all visit

排除标准

  • Osteoporosis,
  • Hyper-/Hypocalcemia,
  • Hyper-/Hypophosphatemia,
  • Hypercalcuria,
  • Uro-/Nephrolithiasis in medical history,
  • Intake of vitamin D-metabolites/-analogues,
  • Intake of cardiac glycosides,
  • Sarkoidosis,
  • Active or intended pregnancy,
  • Hereditary fructose intolerance, glucose-galactose malabsorption, sucrase-isomaltase-deficiency, congenital galactose intolerance, congenital lactase defiency,
  • Pseudohypoparathyreodism,
  • Life threatening disease with statistical life expectancy < 12 months,
  • Former participation in this study or articipation in a clinical trial with intake of an investigational

研究者

发起方
Deutsches Schwindel- und Gleichgewichtszentrum DSGZ und Neurologische Klinik, Klinikum der Universität München

相似试验